国邦医药
(605507)
| 流通市值：122.91亿 | | | 总市值：122.91亿 |
| 流通股本：7.82亿 | | | 总股本：7.82亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,226,170,184.73 | 1,439,416,245.38 | 1,511,599,155.4 | 1,460,007,401.61 |
| 交易性金融资产 | 1,276,492,620.81 | 1,075,022,452.64 | 1,253,626,666.81 | 1,242,959,821.37 |
| 应收票据及应收账款 | 887,412,381.32 | 905,257,203.83 | 1,016,832,203.05 | 859,327,348.29 |
| 应收账款 | 887,412,381.32 | 905,257,203.83 | 1,016,832,203.05 | 859,327,348.29 |
| 应收款项融资 | 476,545,373.23 | 478,570,725.69 | 586,848,039.57 | 535,130,099.7 |
| 预付款项 | 542,309,853.96 | 661,477,937.93 | 396,224,327.11 | 195,881,971.73 |
| 其他应收款合计 | 10,373,706.71 | 7,849,857.19 | 6,775,524.22 | 6,574,451.28 |
| 存货 | 1,787,597,535.42 | 1,867,966,223.51 | 1,740,525,848.9 | 1,776,151,615.01 |
| 其他流动资产 | 17,469,556.42 | 35,191,019.94 | 19,260,582.97 | 36,816,099.73 |
| 流动资产合计 | 6,224,371,212.6 | 6,470,751,666.11 | 6,531,692,348.03 | 6,112,848,808.72 |
| 非流动资产: | | | | |
| 长期股权投资 | 154,380,270.1 | 94,797,264.06 | 96,950,355.92 | 98,707,996.63 |
| 其他非流动金融资产 | 20,000,000 | 20,000,000 | 20,000,000 | 20,000,000 |
| 投资性房地产 | 64,762,413.03 | 65,738,730.81 | 66,715,048.59 | 67,691,366.37 |
| 固定资产 | 4,000,682,184.64 | 3,971,809,028.95 | 3,904,402,718.46 | 4,006,121,443.13 |
| 在建工程 | 367,377,567.21 | 380,738,124.88 | 398,495,698.17 | 282,875,810.07 |
| 无形资产 | 372,302,013.97 | 339,653,545.75 | 341,692,184.37 | 342,650,262.46 |
| 商誉 | 25,487.37 | 25,487.37 | 25,487.37 | 25,487.37 |
| 长期待摊费用 | 6,626,297.18 | 6,743,794.61 | 6,861,292.04 | 6,978,789.47 |
| 递延所得税资产 | 16,468,069.46 | 16,785,114.21 | 13,592,934.13 | 13,518,190.43 |
| 其他非流动资产 | 35,356,674.47 | 16,276,617.1 | 15,366,868.5 | 33,217,513.3 |
| 非流动资产合计 | 5,037,980,977.43 | 4,912,567,707.74 | 4,864,102,587.55 | 4,871,786,859.23 |
| 资产总计 | 11,262,352,190.03 | 11,383,319,373.85 | 11,395,794,935.58 | 10,984,635,667.95 |
| 流动负债: | | | | |
| 短期借款 | 365,116,097.22 | 431,140,197.22 | 511,071,192.22 | 506,101,061.66 |
| 交易性金融负债 | 46,539.47 | 46,539.47 | - | - |
| 应付票据及应付账款 | 1,562,580,472.91 | 1,725,222,731.46 | 1,466,102,594.29 | 1,196,294,764.16 |
| 其中：应付票据 | 1,058,044,040.79 | 1,173,932,093.8 | 929,807,230.53 | 661,131,748.42 |
| 应付账款 | 504,536,432.12 | 551,290,637.66 | 536,295,363.76 | 535,163,015.74 |
| 合同负债 | 40,993,355.12 | 40,453,602.41 | 43,785,071.3 | 25,348,093.15 |
| 应付职工薪酬 | 77,074,809.39 | 91,742,877.28 | 62,030,317.27 | 107,023,668.18 |
| 应交税费 | 45,155,042.18 | 36,658,085.18 | 52,095,976.96 | 47,275,180.12 |
| 其他应付款合计 | 32,650,026.3 | 33,430,889.98 | 33,056,260.23 | 30,388,978.13 |
| 一年内到期的非流动负债 | 419,200,000 | 413,342,142.36 | 400,320,000 | 7,293,215.43 |
| 其他流动负债 | 2,265,347.12 | 2,769,939.07 | 2,629,997.5 | 1,537,372.92 |
| 流动负债合计 | 2,545,081,689.71 | 2,774,807,004.43 | 2,571,091,409.77 | 1,921,262,333.75 |
| 非流动负债: | | | | |
| 长期借款 | 168,616,935.99 | 176,571,135.02 | 82,883,009.06 | 478,011,135.02 |
| 递延收益 | 30,487,023.08 | 28,586,657 | 25,047,103.49 | 25,861,661.5 |
| 递延所得税负债 | 1,409,532.85 | 1,676,001.2 | 1,088,259.63 | 3,944,017.61 |
| 非流动负债合计 | 200,513,491.92 | 206,833,793.22 | 109,018,372.18 | 507,816,814.13 |
| 负债合计 | 2,745,595,181.63 | 2,981,640,797.65 | 2,680,109,781.95 | 2,429,079,147.88 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 782,352,900 | 782,352,900 | 558,823,500 | 558,823,500 |
| 资本公积 | 3,403,905,558.46 | 3,403,905,558.46 | 3,627,434,958.46 | 3,627,434,958.46 |
| 减:库存股 | 175,133,816.06 | 159,906,318 | - | - |
| 盈余公积 | 241,311,960.71 | 241,311,960.71 | 241,311,960.71 | 241,311,960.71 |
| 未分配利润 | 4,261,621,283.94 | 4,131,607,281.82 | 4,286,182,992.51 | 4,125,553,317.83 |
| 归属于母公司股东权益合计 | 8,514,057,887.05 | 8,399,271,382.99 | 8,713,753,411.68 | 8,553,123,737 |
| 少数股东权益 | 2,699,121.35 | 2,407,193.21 | 1,931,741.95 | 2,432,783.07 |
| 股东权益合计 | 8,516,757,008.4 | 8,401,678,576.2 | 8,715,685,153.63 | 8,555,556,520.07 |
| 负债和股东权益合计 | 11,262,352,190.03 | 11,383,319,373.85 | 11,395,794,935.58 | 10,984,635,667.95 |
| 公告日期 | 2026-10-24 | 2026-08-01 | 2026-04-16 | 2026-03-28 |
| 审计意见(境内) | | | | 标准无保留意见 |